Hue L, Blackmore P F, Exton J H
J Biol Chem. 1981 Sep 10;256(17):8900-3.
Vasopressin, phenylephrine, and A23187 cause an accumulation of fructose 2,6-bisphosphate in hepatocytes from fed rats, but not in Ca2+-depleted hepatocytes from fed rats or in phosphorylase kinase-deficient hepatocytes from (gsd/gsd) rats. The effect of vasopressin and phenylephrine is not found in hepatocytes from overnight-starved rats. Thus, the accumulation of fructose 2,6-bisphosphate by these agents may depend on the stimulation of glycogenolysis and on the resulting accumulation of hexose 6-phosphate. In support of this hypothesis, conditions are described for the enzymatic synthesis of fructose 2,6-bisphosphate from fructose 6-phosphate and Mg-ATP in liver extracts. Half-maximal activity (0.8 nmol/min.g) is obtained with about 60 microM fructose 6-phosphate, and the activity can be separated fom phosphofructokinase by ammonium sulfate fractionation. Treatment of rats or isolated hepatocytes with glucagon results in a 4-5-fold decrease in the maximal activity of this enzyme.
血管加压素、去氧肾上腺素和A23187可使喂食大鼠的肝细胞中果糖2,6-二磷酸积聚,但在喂食大鼠的钙缺乏肝细胞或(gsd/gsd)大鼠的磷酸化酶激酶缺陷肝细胞中则不会。过夜饥饿大鼠的肝细胞未发现血管加压素和去氧肾上腺素的这种作用。因此,这些药物导致的果糖2,6-二磷酸积聚可能依赖于糖原分解的刺激以及由此产生的6-磷酸己糖积聚。为支持这一假说,本文描述了在肝脏提取物中由6-磷酸果糖和Mg-ATP酶促合成果糖2,6-二磷酸的条件。约60μM的6-磷酸果糖可获得半数最大活性(0.8 nmol/分钟·克),并且该活性可通过硫酸铵分级分离与磷酸果糖激酶分离。用胰高血糖素处理大鼠或分离的肝细胞会导致该酶的最大活性降低4至5倍。